Assignee
XERIS PHARMACEUTICALS INC
US·23 granted patents·17 pending applications·81 citations·filing 2012–2025
Top patents by PatentIndex Score
40 records- 0193US9649364B2Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2016·Granted May 16, 2017·12 cites·16 claims
- 0292US9642894B2Compositions for rapidly treating severe hypoglycemiaXERIS PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·5 cites·2 claims
- 0391US10485850B2Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2017·Granted Nov 26, 2019·8 cites·12 claims
- 0490US9339545B2Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·13 cites·27 claims
- 0589US11020403B2Precipitation resistant small molecule drug formulationsXERIS PHARMACEUTICALS INC·Filed 2018·Granted Jun 1, 2021·4 cites·22 claims
- 0688US9125805B2Stable formulations for parenteral injection of small molecule drugsXERIS PHARMACEUTICALS INC·Filed 2013·Granted Sep 8, 2015·12 cites·8 claims
- 0787US12514837B2Stable levothyroxine compositions in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2024·Granted Jan 6, 2026·1 cites·6 claims
- 0887US12377096B2Methods of treating disease with levoketoconazoleXERIS PHARMACEUTICALS INC·Filed 2024·Granted Aug 5, 2025·0 cites·17 claims
- 0987US9138479B2Formulations for the treatment of diabetesXERIS PHARMACEUTICALS INC·Filed 2012·Granted Sep 22, 2015·11 cites·34 claims
- 1086US9018162B2Methods for rapidly treating severe hypoglycemiaXERIS PHARMACEUTICALS INC·Filed 2013·Granted Apr 28, 2015·3 cites·17 claims
- 1186US2024207365A1Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1286US2024342249A1Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1385US2025387389A1Methods of treating disease with levoketoconazoleXERIS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1484US11446310B2Stable formulations for parenteral injection of small molecule drugsXERIS PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·1 cites·21 claims
- 1583US9302010B2Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 5, 2016·5 cites·19 claims
- 1683US2024041984A1Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1779US11964003B2Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2021·Granted Apr 23, 2024·1 cites·47 claims
- 1878US2026076932A1Stable levothyroxine compositions in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1976US11590205B2Methods for producing stable therapeutic glucagon formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2016·Granted Feb 28, 2023·1 cites·8 claims
- 2073US2021315961A1Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2172US11957736B2Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2023·Granted Apr 16, 2024·0 cites·24 claims
- 2272US2024316158A1Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2370US2024148680A1Stable levothyroxine compositions in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2469US9314424B2Pastes for injection of a therapeutic agentXERIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 19, 2016·3 cites·20 claims
- 2567US12514907B2Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetesXERIS PHARMACEUTICALS INC·Filed 2023·Granted Jan 6, 2026·0 cites·27 claims
- 2667US2024238381A1Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2767US2020215162A1Methods for Producing Stable Therapeutic Formulations in Aprotic Polar SolventsXERIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2866US11833157B2Precipitation resistant small molecule drug formulationsXERIS PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·0 cites·25 claims
- 2964US10987399B2Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2016·Granted Apr 27, 2021·0 cites·16 claims
- 3063US11129940B2Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastesXERIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 28, 2021·1 cites·16 claims
- 3163US9295724B2Stable formulations for parenteral injection of peptide drugsXERIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 29, 2016·0 cites·27 claims
- 3262US11576951B2Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·33 claims
- 3362US2024148678A1Sustained release injectable therapeutic formulations using aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3460US10765683B2Stable formulations for parenteral injection of small molecule drugsXERIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 8, 2020·0 cites·13 claims
- 3558US2023085357A1Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereofXERIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3643US2021030847A1Treatment of post-bariatric hypoglycemia using mini-dose stable glucagonXERIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3739US2021008170A1Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetesXERIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3838US2019083578A1Use of low dose glucagonXERIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3935US2020147306A1Methods for treating congenital hyperinsulinismXERIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4033US2017007675A1Stable peptide formulations and methods for preparationXERIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when XERIS PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →